☆ 4.6 Review

State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

Pancreatic Cancer Resistance to Treatment: The Role of Microbiota

Enrico Celestino Nista et al.

Summary: Pancreatic cancer is a challenging malignancy with high mortality rates. Microbes, particularly certain bacteria, have been found to play a role in therapy resistance and tumor microenvironment, affecting cancer progression and treatment outcomes. Understanding the interactions between microbiota and therapy may lead to improved treatment strategies and survival for patients with pancreatic cancer.

BIOMEDICINES (2023)

Add to Collection

Article Medicine, General & Internal

STNM01, the RNA oligonucleotide targeting carbohydrate sulfotransferase 15, as second-line therapy for chemotherapy-refractory patients with unresectable pancreatic cancer: An open label, phase I/IIa trial

Toshio Fujisawa et al.

Summary: This study aimed to evaluate the safety and efficacy of STNM01 in combination with S-1 as second-line therapy for unresectable pancreatic ductal adenocarcinoma. The results showed that the combination therapy of STNM01 and S-1 prolonged overall survival and increased T cell infiltration in the tumor microenvironment.

ECLINICALMEDICINE (2023)

Add to Collection

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Add to Collection

Article Oncology

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

Eva Versteijne et al.

Summary: This study investigates the impact of neoadjuvant chemoradiotherapy on the survival of patients with resectable and borderline resectable pancreatic cancer. The results demonstrate that neoadjuvant chemoradiotherapy improves overall survival compared to upfront surgery in these patients.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

First data for sotorasib in patients with pancreatic cancer with KRAS p.G12C mutation: A phase I/II study evaluating efficacy and safety

John H Strickler et al.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Health Care Sciences & Services

Improving Palliative Care and Quality of Life in Pancreatic Cancer Patients

Vincent Chung et al.

Summary: This study conducted a secondary analysis on palliative care intervention for pancreatic cancer patients, showing that the intervention may improve patients' QOL and psychological distress. However, a larger phase III trial focusing on pancreatic cancer patients is needed to confirm the effectiveness of the intervention.

JOURNAL OF PALLIATIVE MEDICINE (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

A meta-analysis evaluating the role of high-intensity focused ultrasound (HIFU) as a fourth treatment modality for patients with locally advanced pancreatic cancer

Maria P. Fergadi et al.

Summary: The study found that HIFU treatment in patients with advanced pancreatic cancer led to increased median overall survival, reduced pain levels when used in conjunction with chemotherapy, and significant reduction in CA19-9 levels. The treatment was also shown to be safe with low incidence of complications.

ABDOMINAL RADIOLOGY (2022)

Add to Collection

Article Oncology

BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients

Ji Hoon Park et al.

Summary: This study investigated the proportion of BRCA 1/2 germline mutations in patients with pancreatic ductal adenocarcinoma (PDAC) and its impact on the response to FOLFIRINOX chemotherapy. The presence of germline BRCA 1/2 mutations was associated with a higher overall response rate in patients treated with FOLFIRINOX. The findings suggest that germline testing should be performed to predict treatment response in PDAC patients.

CANCERS (2022)

Add to Collection

Article Oncology

Precision Medicine for BRCA/PALB2-Mutated Pancreatic Cancer and Emerging Strategies to Improve Therapeutic Responses to PARP Inhibition

Daniel R. Principe

Summary: For a small subset of pancreatic ductal adenocarcinoma (PDAC) patients with loss-of-function mutations in BRCA1/2 or PALB2, first-line and maintenance therapy differ significantly due to the loss of double-strand break DNA homologous recombination (HR). Current treatment guidelines emphasize specific strategies for PDAC tumors deficient in HR, along with emerging approaches to improve drug responses.

CANCERS (2022)

Add to Collection

Review Gastroenterology & Hepatology

Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment

Laura D. Wood et al.

Summary: This review discusses the pathogenesis, early detection methods, and treatment considerations of pancreatic ductal adenocarcinoma (PDAC). Recent advances in understanding PDAC have led to significant improvements in detection and treatment, but coordinated efforts are needed to maximize clinical impact for patients and overall survival.

GASTROENTEROLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients

Bruna Dalmasso et al.

Summary: The BRCA1/2 genes play a crucial role in breast, ovarian, pancreatic and prostate cancers. Other genes involved in homologous recombination and DNA damage response are being studied as potential targets for treatment. However, these genes are not routinely tested worldwide. This study summarizes the genetic and cellular burden of these genes and suggests that including DDR genes shared by both pancreatic and prostate cancers can lead to better detection of actionable variants.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Medicine, General & Internal

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer

Rom Leidner et al.

Summary: The patient with progressive metastatic pancreatic cancer showed regression of visceral metastases after receiving infusion of genetically engineered autologous T cells targeting mutant KRAS G12D, with an overall partial response of 72% according to the Response Evaluation Criteria in Solid Tumors, version 1.1. The response was ongoing at 6 months, and the engineered T cells accounted for more than 2% of all circulating peripheral-blood T cells.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Review Gastroenterology & Hepatology

Venous resection for pancreatic cancer, a safe and feasible option? A review and meta

E. S. Zwart et al.

Summary: This meta-analysis compared the mortality, morbidity, and long-term survival of pancreatic resections with and without venous resection in patients with pancreatic ductal adenocarcinoma. The results showed that patients undergoing venous resection had a higher risk of postoperative hemorrhage, incomplete resection, lymph node metastasis, and larger tumors. However, overall survival and complication rates were comparable between the two groups. This suggests that venous resection is a safe and feasible option for patients with suspected venous involvement in pancreatic cancer.

PANCREATOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer

J. H. Strickler et al.

Summary: This study evaluated the safety and efficacy of sotorasib in patients with KRAS p.G12C-mutated pancreatic cancer who had previously received treatment. The results showed that sotorasib demonstrated anticancer activity and had an acceptable safety profile in these patients.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Oncology

KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced/metastatic non–small cell lung cancer (NSCLC) harboring a KRASG12C mutation.

Alexander I. Spira et al.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Review Oncology

Thermal ablation in pancreatic cancer: A scoping review of clinical studies

William Farmer et al.

Summary: Pancreatic cancer is a deadly cancer with limited surgical options. Thermal ablation techniques, such as radiofrequency ablation and high-intensity focused ultrasound, are safe and feasible alternatives to surgery in the management of pancreatic cancer. However, the evidence for the benefit of microwave ablation and laser ablation is limited.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Oncology

Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection

Manxiong Dai et al.

Summary: This study aimed to investigate the distribution of KRAS mutant subtypes in resectable pancreatic ductal adenocarcinoma (PDAC) patients in China and evaluate the prognostic value of different subtypes in patients undergoing radical resection. The results showed that KRAS-G12D mutation was associated with shorter overall survival (OS), while KRAS wild-type was associated with longer OS.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Oncology

Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer

Yangyang Ma et al.

Summary: This study analyzed the safety and effectiveness of simultaneous gemcitabine and percutaneous CT-guided irreversible electroporation (IRE) therapy for locally advanced pancreatic cancer (LAPC), finding that this treatment model can prolong the overall survival, local tumor progression free survival, and distant disease free survival in patients. Tumor volume and simultaneous gemcitabine with IRE were identified as significant independent prognostic factors. The occurrence of major adverse reactions was low and resolved with symptomatic treatment.

JOURNAL OF ONCOLOGY (2022)

Add to Collection

Article Oncology

Cytotoxic Chemotherapy in Advanced Pancreatic Cancer

Muneeb Rehman et al.

Summary: Despite progress in understanding PDAC tumor biology, treatment options for metastatic pancreatic cancer are still limited. However, with a better understanding of tumor biology, noncytotoxic agents, and the interest from academia and pharmaceutical companies, improved systemic treatment is expected in the future.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2022)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Benefitial role of electrochemotherapy in locally advanced pancreatic cancer-radiological perspective

Oliwia Kozak et al.

Summary: Irreversible electroporation is an increasingly used method in the treatment of pancreatic cancer, which causes cell apoptosis by damaging the cell membrane without destroying the stroma. Combining this method with chemotherapy can improve the treatment effectiveness.

POLISH JOURNAL OF RADIOLOGY (2022)

Add to Collection

Article Oncology

Surgical Outcomes After Total Pancreatectomy: A High-Volume Center Experience

Thomas F. Stoop et al.

Summary: In a study at a single, high-volume center, an increase in the surgical volume of total pancreatectomy was associated with improved perioperative outcomes, especially for extended resections.

ANNALS OF SURGICAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Total Neoadjuvant Therapy for Operable Pancreatic Cancer

Rebecca Y. Kim et al.

Summary: The study found that total neoadjuvant therapy (TNT) can ensure the delivery of intended systemic therapy before a complicated operation without decreasing the chance of successful surgery. Patients who can tolerate shorter course neoadjuvant therapy (SNT) may also benefit from total neoadjuvant therapy (TNT).

ANNALS OF SURGICAL ONCOLOGY (2021)

Add to Collection

Article Surgery

Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma

Hordur Kolbeinsson et al.

Summary: Pancreatic ductal adenocarcinoma has a high rate of recurrence after resection, with liver metastasis being the most common distant site of recurrence. Patients with poorly differentiated tumors are more likely to recur in the liver. Liver-directed therapies should be a focus for future studies.

SURGERY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection

Johannes F. Fahrmann et al.

Summary: CA19-9 serves as an anchor marker for pancreatic cancer early detection, especially with exponentially increasing levels starting 2 years before diagnosis, providing significant value for early diagnosis.

GASTROENTEROLOGY (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Cell Biology

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells

Yibo Fu et al.

Summary: Mitochondria play important roles in the chemoresistance of pancreatic cancer by affecting apoptosis, metabolism, mtDNA metabolism, and mitochondrial dynamics. Targeting certain factors in mitochondria may improve the sensitivity of pancreatic cancer cells to chemotherapeutic agents.

CELLS (2021)

Add to Collection

Article Oncology

Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC)

Dimitrios Oikonomou et al.

Summary: The combination of chemotherapy with IRE is a safe and effective treatment for LAPC, which may result in a survival benefit for patients.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2021)

Add to Collection

Article Medicine, Research & Experimental

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial

M. S. Walma et al.

Summary: The PELICAN trial aims to assess whether the combination of chemotherapy and RFA can improve overall survival compared to chemotherapy alone in patients with LAPC with no disease progression after 2 months of systemic treatment.

TRIALS (2021)

Add to Collection

Review Gastroenterology & Hepatology

Endoscopic ultrasonography-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer: An update

Guillermo Perez-Aguado et al.

Summary: EUS-CPN is an alternative for pain control in patients with nonsurgical pancreatic cancer, involves injection of alcohol and a local anesthetic into the area of the celiac plexus to achieve chemical ablation of the nerve tissue. The efficacy of EUS-CPN varies from 50% to 94% in the different studies, and it has a pain relief duration of 4-8 weeks.

WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY (2021)

Add to Collection

Review Immunology

Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins

Sophie Liot et al.

Summary: Pancreatic cancer, especially PDAC, has a poor prognosis with low survival rates, mainly due to its dense stroma deposition and immune suppression in the TME. Research on TME composition may lead to new therapeutic targets for better treatment outcomes.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Irreversible Electroporation (IRE) in Locally Advanced Pancreatic Cancer: A Review of Current Clinical Outcomes, Mechanism of Action and Opportunities for Synergistic Therapy

Zainab L. Rai et al.

Summary: IRE treatment may improve the survival of patients with locally advanced pancreatic cancer, but it comes with a high rate of complications. The mechanism of action of IRE remains unknown, but emerging data suggests that it can be augmented with synergistic therapies such as immunotherapy to enhance efficacy.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies

Marwa Elsayed et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is currently the fourth leading cause of cancer deaths in the US, with projections to become the second leading cause by 2030. The lack of effective early screening tests, undetectable micro-metastasis at presentation, low mutation burden, immunological profile, dense tumor stroma, and decreased tumor sensitivity to drugs all contribute to the low survival rates in PDAC patients. Researchers must focus on understanding PDAC pathology and immunological behavior, and utilize advanced screening modalities and new therapeutic agents for improved outcomes.

BIOMEDICINES (2021)

Add to Collection

Review Medicine, General & Internal

Pancreatic Cancer: A Review

Wungki Park et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer with increasing incidence each year, resulting in a high percentage of patients being diagnosed with advanced disease. Current cytotoxic therapies for PDAC are moderately effective, emphasizing the importance of multidisciplinary management, comprehensive germline testing, and integrated supportive care for all patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Oncology

Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial

Laetitia Dahan et al.

Summary: This study found that maintenance treatment with leucovorin plus fluorouracil is feasible and effective in patients with mPC controlled after 4 months of induction chemotherapy with FOLFIRINOX. However, there was a higher incidence of severe neurotoxicity in the maintenance therapy arm.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial

Isabella Frigerio et al.

Summary: This study compared the efficacy of radiofrequency ablation (RFA) and conventional chemoradiotherapy (CHRT) in patients with locally advanced pancreatic cancer. The results showed that RFA alone did not provide any significant advantage in overall survival (OS) or progression-free survival (PFS) compared to CHRT.

PANCREATOLOGY (2021)

Add to Collection

Article Oncology

New therapeutic strategy: Personalization of pancreatic cancer treatment-irreversible electroporation (IRE), electrochemotherapy (ECT) and calcium electroporation (CaEP) - A pilot preclinical study

Julia Rudno-Rudzinska et al.

Summary: The study investigated IRE, ECT, and CaEP as new strategies for human pancreatic cancer. Procedures were found to be safe and showed higher overall survival rates compared to traditional chemotherapy.

SURGICAL ONCOLOGY-OXFORD (2021)

Add to Collection

Review Gastroenterology & Hepatology

Pancreatic cancer in 2021: What you need to know to win

Valeria Tonini et al.

Summary: Pancreatic cancer has a poor prognosis, with a less than 10% five-year survival rate. Surgical resection is the only potentially curative treatment, but the tumor is often diagnosed late in the disease process and surgery is limited. Post-operative morbidity is high, and other therapies offer disappointing results.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better

Patrick Michl et al.

Summary: Pancreatic ductal adenocarcinoma is a deadly cancer with scarce research funding in Europe, calling for public-private partnerships to support research and improve treatment methods.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

Add to Collection

Review Gastroenterology & Hepatology

Diet and Exercise Interventions in Patients With Pancreatic Cancer A Scoping Review

Popi Kasvis et al.

Summary: The study conducted a scoping review to identify knowledge gaps surrounding diet and exercise interventions in ambulatory patients with pancreatic cancer. Only 62 out of 15,708 articles met the final inclusion criteria, highlighting the limited research in this area and the need for future studies to address important research gaps.

PANCREAS (2021)

Add to Collection

Review Surgery

Technical advances in surgery for pancreatic cancer

M. Schneider et al.

Summary: This review summarizes technical advances in surgery for locally advanced pancreatic ductal adenocarcinoma (PDAC), including new approaches like artery-first and uncinate-first methods, as well as techniques for resection and reconstruction to enhance completeness and reduce local recurrence. Advanced surgical techniques provide a toolkit for curative-intent surgery in PDAC, even in cases with arterial or venous involvement, but effects on overall survival still require high-level clinical evidence.

BRITISH JOURNAL OF SURGERY (2021)

Add to Collection

Article Surgery

Robotic versus laparoscopic distal pancreatectomy: multicentre analysis

S. Lof et al.

Summary: A multicentre international propensity score-matched study found that there was no significant difference in major morbidity rates between robotic distal pancreatectomy (RDP) and laparoscopic distal pancreatectomy (LDP). However, RDP showed better conversion rates, spleen preservation rates, and readmission rates compared to LDP.

BRITISH JOURNAL OF SURGERY (2021)

Add to Collection

Article Oncology

Pancreatic Adenocarcinoma, Version 2.2021

Margaret A. Tempero et al.

Summary: Pancreatic cancer is the fourth leading cause of cancer-related death in the United States, with a major challenge being advanced disease at diagnosis. While survival rates have not significantly changed, newer treatments, including targeted therapies, offer hope for patients. The manuscript focuses on systemic therapy approaches for locally advanced and metastatic disease.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Add to Collection

Article Oncology

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer

Shalini Moningi et al.

Summary: This study compared the clinical outcomes of pancreatic cancer patients treated with SBRT with and without fiducial markers. The results showed that the use of fiducial markers did not have a negative impact on local recurrence, overall survival, surgical margins, or lymphovascular invasion in this group of patients. Prospective confirmation of these findings is still required.

ADVANCES IN RADIATION ONCOLOGY (2021)

Add to Collection

Article Oncology

The role of seed implantation in patients with unresectable pancreatic carcinoma after relief of obstructive jaundice using ERCP

Wen Li et al.

BRACHYTHERAPY (2020)

Add to Collection

Article Oncology

Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer

Roberto Petrioli et al.

JOURNAL OF GERIATRIC ONCOLOGY (2020)

Add to Collection

Article Oncology

Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation

Max M. Wattenberg et al.

BRITISH JOURNAL OF CANCER (2020)

Add to Collection

Review Biology

A review on the efficacy and safety of iodine-125 seed implantation in unresectable pancreatic cancers

Sheng-Nan Jia et al.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2020)

Add to Collection

Article Oncology

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation

Eileen M. O'Reilly et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Oncology

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial

Eva Versteijne et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Surgery

Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy

Erika Simmerman et al.

JOURNAL OF SURGICAL RESEARCH (2020)

Add to Collection

Article Gastroenterology & Hepatology

Irreversible electroporation after induction chemotherapy versus chemotherapy alone for patients with locally advanced pancreatic cancer: A propensity score matching analysis

Chaobin He et al.

PANCREATOLOGY (2020)

Add to Collection

Review Surgery

Superior mesenteric artery first approach can improve the clinical outcomes of pancreaticoduodenectomy: A meta-analysis

Xiangyan Jiang et al.

INTERNATIONAL JOURNAL OF SURGERY (2020)

Add to Collection

Review Pharmacology & Pharmacy

New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma

Ritu Raj Singh et al.

DRUGS (2020)

Add to Collection

Review Gastroenterology & Hepatology

AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review

Harry R. Aslanian et al.

GASTROENTEROLOGY (2020)

Add to Collection

Article Microbiology

Predictable modulation of cancer treatment outcomes by the gut microbiota

Yoshitaro Heshiki et al.

MICROBIOME (2020)

Add to Collection

Article Gastroenterology & Hepatology

International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club

William Greenhalf et al.

PANCREATOLOGY (2020)

Add to Collection

Review Oncology

Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer

Michelle McMullen et al.

CANCERS (2020)

Add to Collection

Article Medicine, General & Internal

Pancreatic cancer

Jonathan D Mizrahi et al.

LANCET (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison

Eran van Veldhuisen et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Fifty Years of Surgery for Pancreatic Cancer

Thilo Hackert et al.

PANCREAS (2020)

Add to Collection

Article Oncology

The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers

Jaideep Chakladar et al.

CANCERS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness

Patrycja Gralewska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Oncology

Bratislava Statement: consensus recommendations for improving pancreatic cancer care

Joan Prades et al.

ESMO OPEN (2020)

Add to Collection

Article Gastroenterology & Hepatology

An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine plus /- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol

Manoop S. Bhutani et al.

ENDOSCOPIC ULTRASOUND (2020)

Add to Collection

Review Oncology

Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer

Dimitrios Moris et al.

ANNALS OF SURGICAL ONCOLOGY (2019)

Add to Collection

Meeting Abstract Oncology

Avenger 500, a phase III open-label randomized trial of the combination of CPI-613 with modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas.

Philip Agop Philip et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Meeting Abstract Oncology

The need for improvement in the management of fatigue, depression and pain in pancreatic cancer.

Amy Westermann et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Advanced Pancreatic Cancer: High-Intensity Focused Ultrasound (HIFU) and Other Local Ablative Therapies

Milka Marinova et al.

ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2019)

Add to Collection

Review Anesthesiology

Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence

D. J. Magee et al.

BRITISH JOURNAL OF ANAESTHESIA (2019)

Add to Collection

Article Nutrition & Dietetics

The Effect of Nutrition Intervention with Oral Nutritional Supplements on Pancreatic and Bile Duct Cancer Patients Undergoing Chemotherapy

Seong Hyeon Kim et al.

NUTRIENTS (2019)

Add to Collection

Article Oncology

Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer

B. Lee et al.

ANNALS OF ONCOLOGY (2019)

Add to Collection

Review Oncology

Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA

Jee-Soo Lee et al.

MOLECULAR ONCOLOGY (2019)

Add to Collection

Review Oncology

Locally Advanced Pancreatic Cancer: Work-Up, Staging, and Local Intervention Strategies

Eran van Veldhuisen et al.

CANCERS (2019)

Add to Collection

Review Oncology

Comparison of overall survival and perioperative outcomes of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis

Yu-Li Jiang et al.

BMC CANCER (2019)

Add to Collection

Article Gastroenterology & Hepatology

Is total laparoscopic pancreaticoduodenectomy superior to open procedure? A meta-analysis

Hua Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Add to Collection

Article Surgery

Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD) A Multicenter Patient-blinded Randomized Controlled Trial

Thijs de Rooij et al.

ANNALS OF SURGERY (2019)

Add to Collection

Article Surgery

Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA)

Jony van Hilst et al.

ANNALS OF SURGERY (2019)

Add to Collection

Review Oncology

Optimizing the outcomes of pancreatic cancer surgery

Oliver Strobel et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Add to Collection

Article Oncology

Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines

M. Fallon et al.

ANNALS OF ONCOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Effects of EUS-guided intratumoral injection of oligonucleotide STNM01 on tumor growth, histology, and overall survival in patients with unresectable pancreatic cancer

Makoto Nishimura et al.

GASTROINTESTINAL ENDOSCOPY (2018)

Add to Collection

Article Public, Environmental & Occupational Health

Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives

E. Molina-Montes et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)

Add to Collection

Review Oncology

Expert consensus statement on computed tomography-guided 125I radioactive seeds permanent interstitial brachytherapy

Junjie Wang et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)

Add to Collection

Review Gastroenterology & Hepatology

Therapeutic developments in pancreatic cancer: current and future perspectives

John P. Neoptolemos et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017

Shuji Isaji et al.

PANCREATOLOGY (2018)

Add to Collection

Article

Radiofrequency assisted pancreaticoduodenectomy for palliative surgical resection of locally advanced pancreatic adenocarcinoma

Jayant Kumar et al.

Oncotarget (2018)

Add to Collection

Article Surgery

R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer

Ihsan Ekin Demir et al.

ANNALS OF SURGERY (2018)

Add to Collection

Article Surgery

Comparison of Perioperative Outcomes Between Laparoscopic and Open Approach for Pancreatoduodenectomy The PADULAP Randomized Controlled Trial

Ignasi Poves et al.

ANNALS OF SURGERY (2018)

Add to Collection

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Review Gastroenterology & Hepatology

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

Andrew McGuigan et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Add to Collection

Review Oncology

Chinese expert consensus on radioactive 125I seeds interstitial implantation brachytherapy for pancreatic cancer

Baodong Gai et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice

Xinjian Xu et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2018)

Add to Collection

Review Health Care Sciences & Services

Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project

Josep Porta-Sales et al.

PALLIATIVE MEDICINE (2017)

Add to Collection

Review Surgery

Systematic review and meta-analysis of robotic versus open pancreaticoduodenectomy

Long Peng et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2017)

Add to Collection

Article Surgery

Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution

John A. Stauffer et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2017)

Add to Collection

Meeting Abstract Oncology

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer

N. Boku et al.

EUROPEAN JOURNAL OF CANCER (2017)

Add to Collection

Article Gastroenterology & Hepatology

EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer

Michael J. Levy et al.

GASTROINTESTINAL ENDOSCOPY (2017)

Add to Collection

Article Oncology

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Alok A. Khorana et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Add to Collection

Article Medicine, General & Internal

The side effects and complications of percutaneous iodine-125 seeds implantation under CT-guide for patients with advanced pancreatic cancer

Wei-Fu Lv et al.

MEDICINE (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Coupling of Homologous Recombination and the Checkpoint by ATR

Remi Buisson et al.

MOLECULAR CELL (2017)

Add to Collection

Article Gastroenterology & Hepatology

Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients

Alessandro Giardino et al.

PANCREATOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

Leore T. Geller et al.

SCIENCE (2017)

Add to Collection

Article Multidisciplinary Sciences

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Dung T. Le et al.

SCIENCE (2017)

Add to Collection

Review Nutrition & Dietetics

Pancreatic Exocrine Insufficiency in Pancreatic Cancer

Miroslav Vujasinovic et al.

NUTRIENTS (2017)

Add to Collection

Article Oncology

An endoscopic ultrasonography-guided interstitial brachytherapy based special treatment-planning system for unresectable pancreatic cancer

Xiaotian Sun et al.

ONCOTARGET (2017)

Add to Collection

Article Oncology

Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline

Stephen Lutz et al.

PRACTICAL RADIATION ONCOLOGY (2017)

Add to Collection

Article Oncology

Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study

B. Schultheis et al.

ANNALS OF ONCOLOGY (2017)

Add to Collection

Review Oncology

Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification

J. W. Gilbert et al.

ANNALS OF ONCOLOGY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy

TaChung Yu et al.

CELL (2017)

Add to Collection

Article Surgery

Pancreatic Cancer Surgery The New R-status Counts

Oliver Strobel et al.

ANNALS OF SURGERY (2017)

Add to Collection

Article Surgery

A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy

Amer H. Zureikat et al.

ANNALS OF SURGERY (2016)

Add to Collection

Article Surgery

Locally Advanced Pancreatic Cancer Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients

Thilo Hackert et al.

ANNALS OF SURGERY (2016)

Add to Collection

Review Gastroenterology & Hepatology

Robotic versus laparoscopic distal pancreatectomy - The first meta-analysis

Paschalis Gavriilidis et al.

HPB (2016)

Add to Collection

Article Surgery

Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer

Salvatore Paiella et al.

UPDATES IN SURGERY (2016)

Add to Collection

Article Pathology

Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma

Maziar Riazy et al.

MODERN PATHOLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Population Attributable Risk for Pancreatic Cancer in Northern Italy

Valentina Rosato et al.

PANCREAS (2015)

Add to Collection

Article Acoustics

Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases

Guojing Wang et al.

ULTRASONICS SONOCHEMISTRY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Symptoms of Pancreatic Cancer in Primary Care

Mia Schmidt-Hansen et al.

PANCREAS (2015)

Add to Collection

Article Public, Environmental & Occupational Health

Risk factors for pancreatic cancer: a summary review of meta-analytical studies

Patrick Maisonneuve et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments

Kareem N. Mohni et al.

PLOS ONE (2015)

Add to Collection

Article Surgery

Total Laparoscopic Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma Oncologic Advantages Over Open Approaches?

Kristopher P. Croome et al.

ANNALS OF SURGERY (2014)

Add to Collection

Article Oncology

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers

T. Golan et al.

BRITISH JOURNAL OF CANCER (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine

Johan Vande Voorde et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association

Mahmoud M. Al-Hawary et al.

RADIOLOGY (2014)

Add to Collection

Article Surgery

Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)

Johanna A. M. G. Tol et al.

SURGERY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer

Ching-Wei D. Tzeng et al.

HPB (2014)

Add to Collection

Article Oncology

Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

Matthew H. G. Katz et al.

ANNALS OF SURGICAL ONCOLOGY (2013)

Add to Collection

Review Oncology

Robotic versus Open Pancreatectomy: A Systematic Review and Meta-analysis

Jie Zhang et al.

ANNALS OF SURGICAL ONCOLOGY (2013)

Add to Collection

Article Oncology

Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival

Faruk Tas et al.

MOLECULAR AND CLINICAL ONCOLOGY (2013)

Add to Collection

Review Oncology

Inherited Pancreatic Cancer Syndromes

Sheila Solomon et al.

CANCER JOURNAL (2012)

Add to Collection

Article Oncology

Neoadjuvant Therapy Is Associated With Improved Survival in Resectable Pancreatic Adenocarcinoma

Avo Artinyan et al.

CANCER (2011)

Add to Collection

Review Oncology

Definition and classification of cancer cachexia: an international consensus

Kenneth Fearon et al.

LANCET ONCOLOGY (2011)

Add to Collection

Article Oncology

Psychological distress in patients with pancreatic cancer-an understudied group

Karen L. Clark et al.

PSYCHO-ONCOLOGY (2010)

Add to Collection

Review Medicine, General & Internal

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

Sonja Gillen et al.

PLOS MEDICINE (2010)

Add to Collection

Article Oncology

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

Matthew H. G. Katz et al.

ANNALS OF SURGICAL ONCOLOGY (2009)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy

Nishita Kothary et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2009)

Add to Collection

Article Pharmacology & Pharmacy

The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection:: Implications for cancer therapy

Annelies Bronckaers et al.

BIOCHEMICAL PHARMACOLOGY (2008)

Add to Collection

Article Gastroenterology & Hepatology

EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies

Aline Charabaty Pishvaian et al.

GASTROINTESTINAL ENDOSCOPY (2006)

Add to Collection

Article Oncology

Borderline resectable pancreatic cancer: Definitions, management, and role of preoperative therapy

Gauri R. Varadhachary et al.

ANNALS OF SURGICAL ONCOLOGY (2006)

Add to Collection

Article Surgery

Robotic resection of pancreatic neuroendocrine tumor

WS Melvin et al.

JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES-PART A (2003)

Add to Collection

Article Medicine, General & Internal

Hospital volume and surgical mortality in the United States.

JD Birkmeyer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.